Search for content, post, videos

Bonesupport to the French market


BONESUPPORT announces that it has signed an Agency agreement with Novomedics to provide it with local support to initiate access to French market.

Novomedics, which is based in Metz, has significant experience in the bone substitute field. BONESUPPORT’s CERAMENT product line of CERAMENT BONE VOID FILLER (BVF), CERAMENT G and CERAMENT V will be commercialized by a national sales force composed of approximately 40 experienced representatives. These representatives have access to a network of potential customers in the orthopaedic sector. Novomedics is led by its Founder & CEO, Michael Class, MD, a French-trained physician.

“I am pleased that we have been able to sign this commercialization agreement with Novomedics in order to initiate coverage of the French market for our highly differentiated injectable bio-ceramic bone substitute products.  We have been very impressed with their knowledge of the bone substitute market and their strong links with the orthopedic community. We look forward to a mutually beneficial relationship,” says Richard Davies, CEO of BONESUPPORT.